Annovis Bio: Embracing Novel Approaches to Parkinson’s and Alzheimer’s Diseases

Published on :

Annovis Bio: Embracing Novel Approaches to Parkinson’s and Alzheimer’s Diseases By Mark Terry April 21, 2023 In a recent conference call and announcement, Berwyn, Penn.-based Annovis Bio discussed its progress [….]

NeuroNascent Takes New Path for Alzheimer’s Treatment

Published on :

Alzheimer’s disease has been one of the toughest disorders for drugmakers to tackle, with multiple trial failures year after year. Companies have exhausted resources as they examined different pathways in what have mostly been futile attempts to develop a therapeutic to halt or delay the onset of this devastating neurodegenerative disease.

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders

Published on :

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders Several Maryland Biotech Firms Are Blazing New Trails in Gene Therapy, Drugs and Diagnostics for Neurological [….]

3 Promising Maryland Biotechs that are Targeting Neurological Disorders

Published on :

3 Promising Maryland Biotechs that are Targeting Neurological Disorders BrainScope, AgeneBio and Neuraly February 13, 2019 Neurological disorders are diseases of the central nervous system such as Alzheimer’s and Parkinson’s. [….]